{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:56:55Z","timestamp":1789660615363,"version":"4.0.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Colistin, a cationic polypeptide antibiotic of the polymyxin class has come back into use due to its potent antimicrobial activity against multidrug-resistant Gram-negative bacteria and the lack of new antibiotics. The purpose of this study was to assess the critically ill infants treated with colistin in our neonatal intensive care unit and to identify predisposing factors for the emergence of acute kidney injury (AKI) following colistin treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective case-control study that included infants with proven or suspected nosocomial infections in the neonatal intensive care unit of a University Hospital between January 2012 and March 2022. Over the same time period, the clinical and laboratory characteristics and outcomes of patients who received antibiotic combination with colistin were compared to patients who received antibiotic combination without colistin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 77 patients were in the colistin group (ColG) and 77 patients were in the control group. The demographic and clinical characteristics of the study groups were similar. In the ColG compared to the control group, hyponatremia, hypokalemia, hypophosphatemia, hypomagnesia and AKI were all more prevalent (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). The most important finding in our study was the higher incidence of AKI and mortality in ColG, as well as the increasing nephrotoxic effect of other medications when used in conjunction with colistin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>During colistin therapy, newborn infants must be closely monitored for AKI. Clinicians should be aware of an increased incidence of hyponatremia, hypokalemia, hypophosphatemia, hypomagnesia, AKI and its consequences in infants given colistin. As awareness increases, harmful effects will decrease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004130","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:44:03Z","timestamp":1697053443000},"page":"165-169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Ten-year Single Center Experience With Colistin Therapy in NICU"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-1850","authenticated-orcid":false,"given":"Tu\u011fba Barsan","family":"Kaya","sequence":"first","affiliation":[{"name":"Department of Neonatology, Faculty of Medicine, Eski\u015fehir Osmangazi University, Eski\u015fehir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-3594","authenticated-orcid":false,"given":"\u00d6zge","family":"S\u00fcrmeli Onay","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Faculty of Medicine, Eski\u015fehir Osmangazi University, Eski\u015fehir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-0873","authenticated-orcid":false,"given":"\u00d6zge","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Faculty of Medicine, Eski\u015fehir Osmangazi University, Eski\u015fehir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-5737","authenticated-orcid":false,"given":"Ay\u015fe Neslihan","family":"Tekin","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Faculty of Medicine, Eski\u015fehir Osmangazi University, Eski\u015fehir, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.45.3.781-785.2001","article-title":"In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.","volume":"45","author":"Li","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","article-title":"Intravenous colistin administration in neonates.","volume":"30","author":"Jajoo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1055\/s-0034-1371361","article-title":"Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.","volume":"31","author":"Alan","year":"2014","journal-title":"Am J Perinatol"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.pedneo.2016.10.002","article-title":"Colistin use in critically ill neonates: a case\u2013control study.","volume":"58","author":"\u0130pek","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"548","DOI":"10.12659\/MSM.898213","article-title":"Use of colistin in a neonatal intensive care unit: a cohort study of 65 patients.","volume":"23","author":"\u00c7a\u011fan","year":"2017","journal-title":"Med Sci Monit"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network. acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4103\/0971-5916.198682","article-title":"An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country.","volume":"144","author":"Jasani","year":"2016","journal-title":"Indian J Med Res"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century.","volume":"22","author":"Nation","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3855\/jidc.9443","article-title":"Factors determining nephrotoxicity and mortality in critical care patients receiving colistin.","volume":"11","author":"Ciftci","year":"2018","journal-title":"J Infect Dev Ctries"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"C913","DOI":"10.1152\/ajpcell.00437.2003","article-title":"Colistin interactions with the mammalian urothelium.","volume":"286","author":"Lewis","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002329900137","article-title":"Effects of polymyxin B on mammalian urinary bladder.","volume":"154","author":"Berg","year":"1996","journal-title":"J Membr Biol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3109\/0886022X.2013.815091","article-title":"Evaluation of colistin nephrotoxicity administered at different doses in the rat model.","volume":"35","author":"Ghlissi","year":"2013","journal-title":"Ren Fail"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1152\/physiolgenomics.00076.2013","article-title":"Cell cycle arrest in a model of colistin nephrotoxicity.","volume":"45","author":"Eadon","year":"2013","journal-title":"Physiol Genomics"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.00070-14","article-title":"Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways.","volume":"58","author":"Dai","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.02587-12","article-title":"Polymyxin B induces apoptosis in kidney proximal tubular cells.","volume":"57","author":"Azad","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00467-021-05121-9","article-title":"Drug toxicity in the proximal tubule: new models, methods and mechanisms.","volume":"37","author":"Hall","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40272-018-0301-5","article-title":"Efficacy and safety of intravenous colistin in very low birth weight preterm infants.","volume":"20","author":"Ilhan","year":"2018","journal-title":"Paediatr Drugs"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2009.08.021","article-title":"Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin induced renal tubular toxicity in rats.","volume":"620","author":"Li","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.24.4.586","article-title":"Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.","volume":"24","author":"Laurent","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.44.3.665-675.2000","article-title":"Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides.","volume":"44","author":"El Mouedden","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"318","DOI":"10.7883\/yoken.JJID.2014.223","article-title":"Incidence and risk factors for colistin-associated nephrotoxicity.","volume":"68","author":"Temocin","year":"2015","journal-title":"Jpn J Infect Dis"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"795","DOI":"10.24953\/turkjped.2020.05.011","article-title":"Assesment of colistin related side effects in premature neonates.","volume":"62","author":"Aksoy","year":"2020","journal-title":"Turk J Pediatr"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical microbiology and infectious diseases (ESCMID), infectious diseases society of America (IDSA), international society for anti-infective pharmacology (ISAP), society of critical care medicine (SCCM), and society of infectious diseases pharmacists (SIDP).","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/17512433.2021.1933436","article-title":"Prevention of colistin induced nephrotoxicity: a review of preclinical and clinical data.","volume":"14","author":"Jafari","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.47.4.1364-1370.2003","article-title":"Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.00103-08","article-title":"Stability of colistin methanesulfonate in pharmaceutical products and solutions for admin- istration to patients.","volume":"52","author":"Wallace","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2110-5820-1-14","article-title":"Renal and neurological side effects of colistin in critically ill patients.","volume":"1","author":"Spapen","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1586\/14787210.2015.1093933","article-title":"Polymyxin B versus colistin: an update.","volume":"13","author":"Cai","year":"2015","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:03:14Z","timestamp":1749945794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004130","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}